Clinical Trial Update: A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for investigational dulaglutide doses in adults with type 2 diabetes on metformin monotherapy; study completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dulaglutide (dulaglutide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2018-08-24